WAUKESHA, WI (November 6, 2007) – Prodesse, Inc. today announced that clinical trials for Pro hMPV+ have begun. Pro hMPV+ is Prodesse’s second generation real time assay for the rapid detection of human metapneumovirus (hMPV). This is Prodesse’s second respiratory product to begin the FDA clearance process as the company’s flagship ProFlu+™ product was submitted for 510(k) clearance to the FDA in October.
